Cerebrovascular imaging software developer iSchemaView has received approval from Israel's Ministry of Health medical device regulation unit (AMAR) for the use of its Rapid imaging platform in Israel.
As a result, hospitals and clinics in Israel can now utilize the artificial intelligence (AI)-based stroke assessment platform's capabilities for automated analysis of CT perfusion, MR, CT angiography, and Alberta Stroke Program Early CT Score (ASPECTS), according to the company.
